Recombinant SARS E Protein (aa 1-76)

  • Check with publisher
  • Published date: February 7, 2020
    • Shirley, New York, United States

A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. https://www.creative-biolabs.com/vaccine/recombinant-sars-e-protein-aa-1-76-111.htm

Result 0 votes
Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Recombinant SARS S1 Protein [His]

    Recombinant SARS S1 Protein [His]

    Immunology Shirley (New York) February 7, 2020 Check with publisher

    Severe acute respiratory syndrome is a viral respiratory disease in humans which is caused by the SARS coronavirus (SARS-CoV). Between November 2002 and July 2003, an outbreak of SARS in Hong Kong nearly became a pandemic, with 8, 422 cases and 916 d...

  • Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)

    Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)

    Immunology Shirley (New York) February 7, 2020 Check with publisher

    The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organizat...

  • Recombinant CMV Pp150 Protein (aa 862-1048) [His]

    Recombinant CMV Pp150 Protein (aa 862-1048) [His]

    Immunology Shirley (New York) February 7, 2020 Check with publisher

    pp150 (UL32) is a basic phosphoprotein, one of the matrix components. It has been described as highly immunogenic, apparently more so than any other of the HCMV structural proteins. https://www.creative-biolabs.com/vaccine/recombinant-cmv-pp150-prote...